Moxibac 400 mg (Tablet)
Unit Price: ৳ 70.00 (1 x 10: ৳ 700.00)
Strip Price: ৳ 700.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Moxifloxacin hydrochloride tablet |
| Company | Popular pharmaceuticals ltd |
Indications
- Treatment of acute bacterial sinusitis
- Treatment of acute exacerbation of chronic bronchitis
- Treatment of community acquired pneumonia
- Treatment of uncomplicated skin and skin structure infections
- Treatment of complicated skin and skin structure infections
- Treatment of complicated intra-abdominal infections
- Treatment of pelvic inflammatory disease
Pharmacology
- 4th generation synthetic broad spectrum
- Fluoroquinolone class of antibacterial drug
- Inhibits topoisomerase II and IV
Dosage & Administration
- 400 mg once daily for acute bacterial sinusitis (7-10 days)
- 400 mg once daily for acute bacterial exacerbation of chronic bronchitis (5-10 days)
- 400 mg once daily for community-acquired pneumonia (7-14 days)
- 400 mg once daily for uncomplicated skin and skin structure infections (7 days)
- 400 mg once daily for complicated skin and skin structure infections (7-21 days)
- 400 mg once daily for complicated intra-abdominal infections (5-14 days)
- 400 mg once daily for pelvic inflammatory disease (14 days)
Interaction
- Decreased absorption when administered with antacids, sucralfate, multivitamins, and multivalent cations
- Enhanced risk of convulsions with NSAIDs and bleeding with warfarin
Contraindications
- Patients with a history of hypersensitivity to Moxifloxacin or other quinolones
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Headache
- Dizziness
Pregnancy & Lactation
- US FDA pregnancy category C
- Not recommended during pregnancy and lactation
Precautions & Warnings
- Increased risk of tendinitis and tendon rupture
- Discontinue if pain or inflammation in a tendon occurs
- Not for use in patients with known prolongation of the QT interval
- Not for use in patients with uncorrected hypokalemia
- Not for use in patients receiving Class IA or Class III antiarrhythmic agents
Use in Special Populations
- No dose adjustment necessary for patients with renal or hepatic impairment
- Safety and effectiveness in pediatric patients and adolescent less than 18 years of age not established
Therapeutic Class
- 4-Quinolone preparations
Storage Conditions
- Keep in a dry place
- Keep away from light and heat
- Keep out of the reach of children